We are live on ! Find out more
APP

Avantax Planning Partners Portfolio holdings

AUM $4.02B
1-Year Est. Return 20%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+20%
3 Year Est. Return
+51.05%
5 Year Est. Return
+51.22%
10 Year Est. Return
AUM
$2.79B
AUM Growth
-$323M
Cap. Flow
-$496M
Cap. Flow %
-17.8%
Top 10 Hldgs %
54.72%
Holding
493
New
23
Increased
52
Reduced
324
Closed
50
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEG icon
251
Constellation Energy
CEG
$93.2B
$522K 0.02%
2,006
-90
-4% -$17.9K
PNC icon
252
PNC Financial Services
PNC
$101B
$517K 0.02%
2,799
-137
-5% -$24K
PINC
253
DELISTED
Premier
PINC
$516K 0.02%
25,815
IBMM
254
DELISTED
iShares iBonds Dec 2024 Term Muni Bond ETF
IBMM
$515K 0.02%
19,730
-4,504
-19% -$117K
TRV icon
255
Travelers Companies
TRV
$80.5B
$506K 0.02%
2,163
-3
-0.1% -$661
FLOT icon
256
iShares Floating Rate Bond ETF
FLOT
$10.3B
$506K 0.02%
9,919
-3,111
-24% -$158K
AMT icon
257
American Tower
AMT
$79.8B
$506K 0.02%
2,177
-3,660
-63% -$812K
IYW icon
258
iShares US Technology ETF
IYW
$24.8B
$499K 0.02%
3,292
IJJ icon
259
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.9B
$498K 0.02%
4,026
-2,255
-36% -$268K
REGN icon
260
Regeneron Pharmaceuticals
REGN
$79.5B
$496K 0.02%
472
-1
-0.2% -$1.11K
FLEX icon
261
Flex
FLEX
$45.3B
$489K 0.02%
14,625
-1,175
-7% -$36.1K
ALL icon
262
Allstate
ALL
$70.8B
$483K 0.02%
2,546
-481
-16% -$85.4K
BX icon
263
Blackstone
BX
$107B
$483K 0.02%
3,152
-238
-7% -$33K
CSX icon
264
CSX Corp
CSX
$93.9B
$482K 0.02%
13,957
-2,205
-14% -$74.8K
GWW icon
265
W.W. Grainger
GWW
$60.4B
$474K 0.02%
456
+34
+8% +$32.9K
LOW icon
266
Lowe's Companies
LOW
$122B
$473K 0.02%
1,747
-1,188
-40% -$288K
ISRG icon
267
Intuitive Surgical
ISRG
$132B
$473K 0.02%
962
-1,103
-53% -$514K
IDV icon
268
iShares International Select Dividend ETF
IDV
$8.48B
$470K 0.02%
15,550
-87,055
-85% -$2.54M
SPDW icon
269
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.2B
$469K 0.02%
12,495
+652
+6% +$23.5K
ET icon
270
Energy Transfer Partners
ET
$71.2B
$451K 0.02%
28,092
+1,500
+6% +$24.1K
VTIP icon
271
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$446K 0.02%
9,054
+536
+6% +$26.1K
SNPS icon
272
Synopsys
SNPS
$77.7B
$445K 0.02%
878
-590
-40% -$317K
ENB icon
273
Enbridge
ENB
$113B
$442K 0.02%
10,881
+2,782
+34% +$107K
IBMN
274
DELISTED
iShares iBonds Dec 2025 Term Muni Bond ETF
IBMN
$440K 0.02%
16,506
-7,336
-31% -$195K
IBMO icon
275
iShares iBonds Dec 2026 Term Muni Bond ETF
IBMO
$576M
$440K 0.02%
17,139
-7,092
-29% -$181K

Similar funds

Avantax Planning Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Avantax Planning Partners held 493 positions worth $2.79B, down 10% from $3.11B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Avantax Planning Partners withdrew a net $496M in Q3 2024, closing 50 positions and reducing 324 holdings. Its most notable exit was iShares iBonds Dec 2028 Term Corporate ETF, an estimated $2.14M position sold in full.

By sector, the portfolio is most concentrated in Technology at 4.7% of assets, down from 5% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Avantax Planning Partners opened a new position in Vertex Pharmaceuticals worth $397K.

  • Avantax Planning Partners's largest Q3 2024 buy was Vertex Pharmaceuticals: 854 shares worth $397K.
  • Avantax Planning Partners added most to JPMorgan International Bond Opportunities ETF in Q3 2024, an estimated $8.66M increase.
  • Avantax Planning Partners's biggest Q3 2024 reduction was Schwab US Large-Cap Growth ETF, cutting an estimated $59.3M.
  • Avantax Planning Partners fully exited iShares iBonds Dec 2028 Term Corporate ETF in Q3 2024, selling an estimated $2.14M.
  • Avantax Planning Partners's ten largest holdings make up 55% of its $2.79B portfolio in Q3 2024.
  • Avantax Planning Partners opened 23 new positions and closed 50 in Q3 2024.
  • Avantax Planning Partners's portfolio value fell 10% quarter-over-quarter to $2.79B.

Based on Avantax Planning Partners's 13F filing for Q3 2024, filed 14 Nov 2024.